Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion type Assertion NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_head.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion description "[Compounds that destabilize cell surface ENaC, or enhance Nedd4-2 activity in the kidney, could potentially serve as drug targets for hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_provenance.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion evidence source_evidence_literature NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_provenance.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion SIO_000772 18691017 NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_provenance.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion wasDerivedFrom befree-20150227 NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_provenance.
- NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_assertion wasGeneratedBy ECO_0000203 NP870882.RA0vTvOu9jog023ub-OZz8J9YKy_tdle3_vsNjpdGeagw130_provenance.